Webinars |
Pharmaceuticals and Drug Discovery
Pharmaceuticals and Drug Discovery Webinars
Promoted Webinars
All Webinars
Alzheimer's Disease Research
Antibodies
Cell Biology
Conference and Expo
Dynamic Nuclear Polarization
Electron Paramagnetic Resonance (EPR)
Flow Cytometry
Food and Beverage Analysis
High-Content Imaging
Immunology
Immuno-Oncology
Infectious Diseases
Lab Techniques
Laboratory Equipment
Magnetic Resonance Imaging (MRI)
Marketing
Mass Spectrometry
Metabolomics
Microscopy
Nanoparticles
Neurology
Nuclear Magnetic Resonance (NMR) Spectroscopy
Oncology
Pharmaceuticals and Drug Discovery
Preclinical Imaging
Protein Analysis
Research Proteins
Spectroscopy
Titration
Toxicology
Pharmaceuticals and Drug Discovery Webinars
Handheld Raman spectrometers have fundamentally changed how the pharmaceutical industry performs incoming raw material identification.
This webcast explores the use of a portable x-ray fluorescence (XRF) instrument, the Thermo Scientific™ IonicX™, and explains how it can identify ionic salts in seconds and replace traditional time-consuming and resource-intensive wet chemistry and benchtop methods.
This webinar reviews light scattering-based methods for protein characterization and explain their utility, when combined with partially denaturing buffers, in understanding aggregation propensity of monoclonal antibodies (mAbs).
COVID-19 is a global pandemic caused by the SARS-CoV-2 virus. There is a huge worldwide effort underway to discover vaccines and new drugs, and to repurpose old drugs to treat this disease.
The expedited schemes available from global regulatory bodies offer significant advantages for drug product developers. While the basic tenants of quality, safety and efficacy testing remain, such programs have been introduced to rapidly get cutting edge treatments to target patient populations.
Antibody-Drug Conjugates (ADCs) are a rapidly growing class of oncology therapeutics wherein a potent cytotoxic drug is conjugated to the antibody molecule. The impact of drug conjugation on the antibody's conformation needs to be evaluated.
Kinetic Characterization of Covalent Inhibitors on the PHERAstar
A TR-FRET approach to measuring the kinetics of ligand-receptor binding and its application of fragment screening
Receptor function is multifaceted and it is therefore highly advantageous to monitor multiple aspects in live cells and in real-time.
Optimizing the receptor binding kinetics of new drugs can have significant benefits, including improved action duration and enhanced efficacy.
The webinar will update on latest developments in MALDI mass spectrometry for high-throughput screening and CPD profiling (rapifleX MALDI PharmaPulse) and introduce Bruker's new surface plasmon resonance (SPR) instrument, the SIERRA SPR-32.
The presentation will give a current overview of label-free high-throughput MALDI TOF mass spectrometry and its use in drug discovery screening. It will explain the basics of MALDI TOF mass spectrometry and the benefits of label-free screening compared to current labeled approaches.